Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale N Gerding

Showing results (91-100 of 199) with videos related to

Pageof 20
Sort By:
Plos One|February 6, 2014
Spore formation and toxin production in Clostridium difficile biofilmsEkaterina G Semenyuk, Michelle L Laning, Jennifer Foley, et al.
Infection Control and Hospital Epidemiology|May 1, 2010
Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from handsUmair Jabbar, Julie Leischner, Douglas Kasper, et al.
Infection Control and Hospital Epidemiology|April 9, 2014
Community-associated Clostridium difficile infection among veterans with spinal cord injury and disorderSalva N Balbale, Stuart Johnson, Stephen P Burns, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2008
Rifampin and rifaximin resistance in clinical isolates of Clostridium difficileJennifer R O'Connor, Minerva A Galang, Susan P Sambol, et al.
Open Forum Infectious Diseases|October 6, 2016
Clearance of Vancomycin-Resistant <i>Enterococcus</i> Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent <i>Clostridium difficile</i> InfectionErik R Dubberke, Kathleen M Mullane, Dale N Gerding, et al.
Anaerobe|April 29, 2014
International typing study of Clostridium difficileCarl E Manzo, Michelle M Merrigan, Stuart Johnson, et al.
Plos One|February 10, 2016
Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk AnalysisErik R Dubberke, Margaret A Olsen, Dustin Stwalley, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2013
Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficileKristin J Nagaro, S Tyler Phillips, Adam K Cheknis, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|April 6, 2006
Genotypic and phenotypic analysis of Clostridium difficile correlated with previous antibiotic exposureMatthew H Samore, Lata Venkataraman, Paola C DeGirolami, et al.
Journal of Clinical Microbiology|December 4, 2009
Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysisJane W Marsh, Mary M O'Leary, Kathleen A Shutt, et al.
Pageof 20

Showing results (91-100 of 199) with videos related to

Sort By:
Pageof 20
Plos One|February 6, 2014
Spore formation and toxin production in Clostridium difficile biofilmsEkaterina G Semenyuk, Michelle L Laning, Jennifer Foley, et al.
Infection Control and Hospital Epidemiology|May 1, 2010
Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from handsUmair Jabbar, Julie Leischner, Douglas Kasper, et al.
Infection Control and Hospital Epidemiology|April 9, 2014
Community-associated Clostridium difficile infection among veterans with spinal cord injury and disorderSalva N Balbale, Stuart Johnson, Stephen P Burns, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2008
Rifampin and rifaximin resistance in clinical isolates of Clostridium difficileJennifer R O'Connor, Minerva A Galang, Susan P Sambol, et al.
Open Forum Infectious Diseases|October 6, 2016
Clearance of Vancomycin-Resistant <i>Enterococcus</i> Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent <i>Clostridium difficile</i> InfectionErik R Dubberke, Kathleen M Mullane, Dale N Gerding, et al.
Anaerobe|April 29, 2014
International typing study of Clostridium difficileCarl E Manzo, Michelle M Merrigan, Stuart Johnson, et al.
Plos One|February 10, 2016
Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk AnalysisErik R Dubberke, Margaret A Olsen, Dustin Stwalley, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2013
Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficileKristin J Nagaro, S Tyler Phillips, Adam K Cheknis, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|April 6, 2006
Genotypic and phenotypic analysis of Clostridium difficile correlated with previous antibiotic exposureMatthew H Samore, Lata Venkataraman, Paola C DeGirolami, et al.
Journal of Clinical Microbiology|December 4, 2009
Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysisJane W Marsh, Mary M O'Leary, Kathleen A Shutt, et al.
Pageof 20